BioGenerator Ventures is the only investor that invests exclusively in St. Louis companies. Its portfolio of more than 50 active St. Louis startup companies is comprised of many of the region's ...

BioGenerator, St. Louis’ innovative investment fund for biotech startups, has figured out that money often isn’t enough to launch successful companies.

Four new Entrepreneurs In Residence have joined the BioGenerator, a nonprofit subsidiary of BioSTL, to create, lead and support new bioscience companies St. Louis. The Entrepreneurs In Residence ...

One message he wants to drive home: BioGenerator is clearly onto something. Its companies have received more than $2.7 billion in capital from over 250 venture-capital and private-equity sources, ...

BioGenerator Vice President Charlie Bolten, in a statement, called StiqIt "an elegant, consumer-friendly product" with a "significant" market potential.

BioGenerator, the investment arm of local bioscience booster BioSTL, is piloting its co-working lab model at the Helix Center in Creve Coeur.

In its current Series A, Canopy has raised $750,000 from Kingdom Capital and $575,000 from BioGenerator, increasing BioGenerator’s cumulative investment into the company to $875,000.

BioGenerator said Cheryl Watkins-Moore has joined the organization as an entrepreneur in residence. BioGenerator is the nonprofit venture development arm of BioSTL, a regional organization that ...

Explanting the Biogenerator at any time can help removing the stem cells. The creator's foresee that hearts damaged by infarcts have the option of functional treatment.

BioGenerator was named a winner of SSTI’s 2013 “Excellence in TBED” (technology-based economic development) award, recognizing BioGenerator and its programs as national models for investing ...

BioGenerator, the investing arm of St. Louis, Mo.-based economic-development organization BioSTL, has provided undisclosed funding to Edis Solutions Inc., a health-care information technology ...

BioGenerator is the nonprofit venture development organization of BioSTL, a local group working to expand the bioscience industry in St. Louis. Donn Rubin is president and CEO of BioSTL.